Immediate Impact
51 standout
Citing Papers
Selective Inhibition of Na V 1.8 with VX-548 for Acute Pain
2023 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of Karin Glavind being referenced
Long‐term treatment with darifenacin for overactive bladder: results of a 2‐year, open‐label extension study
2006
Incidence and treatment of urinary retention postpartum
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Karin Glavind | 903 | 624 | 333 | 502 | 69 | 1.2k | |
| Daniele Perucchini | 960 | 564 | 282 | 676 | 55 | 1.2k | |
| Montserrat Espuña‐Pons | 952 | 572 | 340 | 565 | 53 | 1.1k | |
| Kate V. Meriwether | 667 | 506 | 201 | 191 | 73 | 988 | |
| Karyn S. Eilber | 618 | 714 | 121 | 332 | 96 | 1.1k | |
| Andrea Braga | 868 | 700 | 215 | 396 | 76 | 1.1k | |
| Jonathan Duckett | 1063 | 736 | 369 | 542 | 91 | 1.2k | |
| Linda D. Cardozo | 1057 | 463 | 380 | 771 | 27 | 1.4k | |
| Sangeeta T. Mahajan | 811 | 466 | 260 | 539 | 84 | 1.4k | |
| Erin T. Bird | 521 | 311 | 152 | 605 | 50 | 988 | |
| Tatiana V. D. Sanses | 756 | 631 | 136 | 203 | 43 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...